Market Overview:
The global HIV self-test kits market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as rising awareness about HIV and its prevention, increasing incidence of HIV, and technological advancements in the field of self-testing. Based on type, the global HIV self-test kits market is segmented into lateral flow immunoassay, immunofiltration, and fluorescent chromatography. Lateral flow immunoassay is the most commonly used type of self-test kit for diagnosis of HIV infection. It accounted for a major share of the global market in 2017. However, fluorescent chromatography is expected to grow at a higher CAGR during the forecast period owing to its advantages over other types such as high sensitivity and specificity levels and low cost per test strip. Based on application, hospitals accounted for the largest share of the global market in 2017 followed by specialty clinics and diagnostic laboratories.
Product Definition:
HIV self-test kits are home testing devices that allow people to test for HIV antibodies in their blood. The kits usually require a small blood sample, which is then placed on a strip or cassette. After a set amount of time, the strip or cassette is read to see if any HIV antibodies have developed. If they have, this means that the person has been infected with HIV and should seek medical attention.
Lateral Flow Immunoassay:
Lateral Flow Immunoassay (LFIA) is a technique used for the detection of specific antigens in biological fluids such as urine, serum, and plasma. It is an analytical tool that helps detect diseases or conditions such as HIV infection in patients' blood samples. The test uses antibodies produced by the immune system to identify and measure particular proteins present on cell membranes of infected cells.
Immunofiltration:
Immunofiltration is a technique used to separate antibodies from the blood. It is also known as antibody filtration and antigen purification. In this process, plasma or serum containing an antibody of interest is passed through a microfilter to remove unwanted proteins, cells & other contaminants. The purified antibodies are then ready for use in diagnostic assays or therapies according to their therapeutic value.
Application Insights:
Based on application, the global HIV self test kits market is segmented into hospitals, specialty clinics, diagnostic laboratories and research institutes. Hospitals held the largest share in 2017 owing to high usage rate of self-test kits among patients. In addition, hospitals are considered as one of the most prominent places for distribution and dispensing of health care products due to growing awareness about them among patients.
Moreover, a large number of people with HIV/AIDS visits hospital for diagnosis and treatment purposes which further boosts product demand in this segment. Self-test kits are also used by individuals who have been diagnosed with other diseases or have suffered from accidents that may lead to blood clots forming in various parts of body (e.g., legs). Thus these factors contribute towards growth rate observed in this segment during recent years.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing government initiatives for early diagnosis are some factors driving the growth of this regional market. For instance, in August 2016, Gilead Sciences provided USD X rebate on each Nucleic Acid Test (NAT) self-test kit purchased through retail pharmacies in the U.S.
Growth Factors:
- Increasing awareness about HIV and its prevention methods, including the use of self-test kits
- Growing demand for home-based HIV tests due to increasing convenience and privacy concerns
- Rising number of people at risk for HIV infection, especially in developing countries
- Technological advancements that have made self-test kits more accurate and easier to use
- Greater availability of affordable self-test kits due to increased competition among manufacturers
Scope Of The Report
Report Attributes
Report Details
Report Title
HIV Self Test Kits Market Research Report
By Type
Lateral Flow Immunoassay, Immunofiltration, Fluorescent Chromatography
By Application
Hospitals, Specialty Clinics, Diagnostic Laboratories, Research Institutes, Others
By Companies
Roche, Abbott, Bio-Rad Laboratories, Danaher, BD, Atomo Diagnostics, BioSURE UK, Biosynex, bioLytical Laboratories, OraSure Technologies, Chembio Diagnostic Systems, Inc., Sedia Biosciences Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global HIV Self Test Kits Market Report Segments:
The global HIV Self Test Kits market is segmented on the basis of:
Types
Lateral Flow Immunoassay, Immunofiltration, Fluorescent Chromatography
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinics, Diagnostic Laboratories, Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Abbott
- Bio-Rad Laboratories
- Danaher
- BD
- Atomo Diagnostics
- BioSURE UK
- Biosynex
- bioLytical Laboratories
- OraSure Technologies
- Chembio Diagnostic Systems, Inc.
- Sedia Biosciences Corporation
Highlights of The HIV Self Test Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lateral Flow Immunoassay
- Immunofiltration
- Fluorescent Chromatography
- By Application:
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HIV Self Test Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HIV self test kits are a type of home testing kit that can be used to detect the presence of HIV in your blood. These kits typically include a collection tube and instructions for using it, as well as a test strip. You can use these tests to determine whether you have HIV, and if so, how much virus is present in your blood.
Some of the major companies in the hiv self test kits market are Roche, Abbott, Bio-Rad Laboratories, Danaher, BD, Atomo Diagnostics, BioSURE UK, Biosynex, bioLytical Laboratories, OraSure Technologies, Chembio Diagnostic Systems, Inc., Sedia Biosciences Corporation.
The hiv self test kits market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 HIV Self Test Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 HIV Self Test Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 HIV Self Test Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the HIV Self Test Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global HIV Self Test Kits Market Size & Forecast, 2020-2028
4.5.1 HIV Self Test Kits Market Size and Y-o-Y Growth
4.5.2 HIV Self Test Kits Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Lateral Flow Immunoassay
5.2.2 Immunofiltration
5.2.3 Fluorescent Chromatography
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Clinics
6.2.3 Diagnostic Laboratories
6.2.4 Research Institutes
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global HIV Self Test Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 HIV Self Test Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Lateral Flow Immunoassay
9.6.2 Immunofiltration
9.6.3 Fluorescent Chromatography
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Clinics
9.10.3 Diagnostic Laboratories
9.10.4 Research Institutes
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Lateral Flow Immunoassay
10.6.2 Immunofiltration
10.6.3 Fluorescent Chromatography
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Clinics
10.10.3 Diagnostic Laboratories
10.10.4 Research Institutes
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Lateral Flow Immunoassay
11.6.2 Immunofiltration
11.6.3 Fluorescent Chromatography
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Clinics
11.10.3 Diagnostic Laboratories
11.10.4 Research Institutes
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Lateral Flow Immunoassay
12.6.2 Immunofiltration
12.6.3 Fluorescent Chromatography
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Clinics
12.10.3 Diagnostic Laboratories
12.10.4 Research Institutes
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Lateral Flow Immunoassay
13.6.2 Immunofiltration
13.6.3 Fluorescent Chromatography
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Clinics
13.10.3 Diagnostic Laboratories
13.10.4 Research Institutes
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 HIV Self Test Kits Market: Competitive Dashboard
14.2 Global HIV Self Test Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Abbott
14.3.3 Bio-Rad Laboratories
14.3.4 Danaher
14.3.5 BD
14.3.6 Atomo Diagnostics
14.3.7 BioSURE UK
14.3.8 Biosynex
14.3.9 bioLytical Laboratories
14.3.10 OraSure Technologies
14.3.11 Chembio Diagnostic Systems, Inc.
14.3.12 Sedia Biosciences Corporation
